These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 2683250)

  • 1. Cyclosporine pharmacokinetics in pediatric transplant recipients.
    Wandstrat TL; Schroeder TJ; Myre SA
    Ther Drug Monit; 1989 Sep; 11(5):493-6. PubMed ID: 2683250
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of age on cyclosporine pharmacokinetics in marrow transplant recipients.
    Yee GC; Lennon TP; Gmur DJ; Kennedy MS; Deeg HJ
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1704-5. PubMed ID: 3274407
    [No Abstract]   [Full Text] [Related]  

  • 3. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients.
    Herzberg GZ; Rossi AF; Courtney M; Gelb BD
    J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral cyclosporine pharmacokinetics in pediatric renal and liver transplant recipients.
    Cooney GF; Dunn SP; Kaiser B; Kulinsky AV; Mochon M; Heifets M
    Transplant Proc; 1994 Oct; 26(5):2779-80. PubMed ID: 7940876
    [No Abstract]   [Full Text] [Related]  

  • 5. Cyclosporine pharmacokinetics in pediatric liver transplant recipients: utility of the monoclonal radioimmunoassay single point blood concentration.
    Dunn SP; Cooney GF; Kulinsky AV; Falkenstein K; Kaiser B; Goldsmith B
    Transplant Proc; 1994 Feb; 26(1):151. PubMed ID: 8108916
    [No Abstract]   [Full Text] [Related]  

  • 6. Limitations of cyclosporine C2 monitoring in pediatric heart transplant recipients.
    Hmiel SP; Canter C; Shepherd R; Lassa-Claxton S; Nadler M
    Pediatr Transplant; 2007 Aug; 11(5):524-9. PubMed ID: 17631021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of biliary T tube clamping on cyclosporine pharmacokinetics in liver transplant recipients.
    Tredger JM; Naoumov NV; Steward CM; O'Grady JG; Grevel J; Niven AA; Kelman AW; Whiting B; Williams R
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):512-5. PubMed ID: 3284098
    [No Abstract]   [Full Text] [Related]  

  • 8. Pediatric liver transplantation.
    Phillips SK
    Prog Transplant; 2002 Jun; 12(2):136-54; quiz 155-6. PubMed ID: 12123175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid profiles in pediatric thoracic transplant recipients are determined by their immunosuppressive regimens.
    Law YM; Yim R; Agatisa P; Boyle GJ; Miller SA; Lawrence K; Webber SA
    J Heart Lung Transplant; 2006 Mar; 25(3):276-82. PubMed ID: 16507419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conversion from tacrolimus to cyclosporine microemulsion therapy in liver transplant recipients.
    Ogino S; Hashikura Y; Katsuyama Y; Ikegami T; Nakazawa Y; Urata K; Terada M; Miyagawa S; Kawasaki S
    Transplant Proc; 2004 Mar; 36(2 Suppl):299S-301S. PubMed ID: 15041357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cessation of steroids in pediatric renal transplant recipients treated with cyclosporine, azathioprine, and prednisolone.
    Francis DM; Walker RG; Jones C; Powell H
    Transplant Proc; 1994 Feb; 26(1):99-101. PubMed ID: 8109043
    [No Abstract]   [Full Text] [Related]  

  • 12. Pediatric liver transplant recipients: mortality analysis over 20 years.
    Profumo RJ
    J Insur Med; 2006; 38(1):3-8. PubMed ID: 16642637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tubular effects of cyclosporine in pediatric renal transplant recipients.
    Laine J; Holmberg C
    Transplant Proc; 1996 Aug; 28(4):2104-6. PubMed ID: 8769167
    [No Abstract]   [Full Text] [Related]  

  • 14. Heart and heart-lung transplantation: the Canadian and world experience from December 1967 to September 1985.
    Modry DL; Kaye MP
    Can J Surg; 1986 Jul; 29(4):275-9. PubMed ID: 3089572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppressive drug monitoring of sirolimus and cyclosporine in pediatric patients.
    Oellerich M; Armstrong VW; Streit F; Weber L; Tönshoff B
    Clin Biochem; 2004 Jun; 37(6):424-8. PubMed ID: 15183289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical problems in pediatric heart and heart-lung transplantation. Transplant Team.
    Cicini MP; Marcelletti C
    Rays; 1994; 19(3):366-77. PubMed ID: 7800844
    [No Abstract]   [Full Text] [Related]  

  • 17. Thoracic organ transplantation in the US.
    Edwards LB; Keck BM
    Clin Transpl; 2002; ():29-40. PubMed ID: 12971435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclosporine in pediatric liver transplantation: is there a therapeutic blood level that abrogates rejection?
    Margarit C; Martinez Ibáñez V; Potau N; Iglesias J; Boix Ochoa J
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):369-74. PubMed ID: 3291270
    [No Abstract]   [Full Text] [Related]  

  • 19. Optimizing cyclosporine use in pediatric patients by measuring pretransplant blood levels.
    Bauma WD; Veremis SA; Maddux MS; Pollak R; Mozes MF
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1709-10. PubMed ID: 3274408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pediatric renal transplant experience in Memphis, Tennessee.
    Batisky DL; Wyatt RJ; Fitzwater DS; Gaber AO; Roy S
    Transplant Proc; 1994 Feb; 26(1):54-6. PubMed ID: 8109020
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.